Skip to main content
SpringerLink
Log in

Oral Retinoids for Hidradenitis Suppurativa

  • Chapter
Hidradenitis Suppurativa

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ward A, Brogden RN, Heel RC, Speight TM, Avery GS. Isotretinoin: a review of its pharmacological properties and therapeutic efficacy in acne and related disorders. Drugs 1984; 28: 6–37

    PubMed  CAS  Google Scholar 

  2. Harms M. Systemic isotretinoin. A unique therapeutic effect and its implications in the pathogenesis of acne. Editiones Roche, Basel, Switzerland, 1994

    Google Scholar 

  3. Dalziel K, Barton S, Marks R. The effect of isotretinoin on follicular and sebaceous gland differentiation. Br J Dermatol 1987; 117:317–323

    Article  PubMed  CAS  Google Scholar 

  4. Cunliffe WJ, Jones DH, Pritlove J, Parkin D. Longterm benefits of isotretinoin in acne. Clinical and laboratory studies. In: Saurat JH, Ed. Retinoids: new trends in research and therapy. Karger, Basel, 1985; pp 242–251

    Google Scholar 

  5. Pigatto PD, Floroni A, Riva F, Brugo MA, Morandotti A, Altomare GF, Finzi AF. Effects of isotretinoin on the neutrophil chemotaxis in cystic acne. Dermatologica 1983; 167:16–18

    PubMed  CAS  Google Scholar 

  6. Layton AM, Knaggs H, Taylor J, Cunliffe WJ. Isotretinoin for acne vulgaris — 10 years later: a safe and successful treatment. Br J Dermatol 1993; 129:292–296

    Article  PubMed  CAS  Google Scholar 

  7. Jones DH, Cunliffe WJ, King K. Hidradenitis suppurativa — lack of success with 13-cis-retinoic acid (letter). Br J Dermatol 1982; 107:252

    Google Scholar 

  8. Dicken CH, Powell ST, Spear KL. Evaluation of isotretinoin treatment of hidradenitis suppurativa. J Am Acad Dermatol 1984; 11:500–502

    PubMed  CAS  Google Scholar 

  9. Norris JFB, Cunliffe WJ. Failure of treatment of familial widespread hidradenitis suppurativa with isotretinoin. Clin Exp Dermatol 1986; 11:579–583

    Article  PubMed  CAS  Google Scholar 

  10. Brown CF, Gallup DG, Brown VM. Hidradenitis suppurativa of the anogenital region: response to isotretinoin. Am J Obstet Gynecol 1988; 158:12–15

    PubMed  CAS  Google Scholar 

  11. Mengesha YM, Holcombe TC, Hansen RC. Prepubertal hidradenitis suppurativa: two case reports and review of the literature. Pediatr Dermatol 1999;16:292–296

    Article  PubMed  CAS  Google Scholar 

  12. Boer J, Gemert van MJP. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol 1999;40:73–76

    Article  PubMed  CAS  Google Scholar 

  13. Shalita AR, Cunningham WJ, Leyden JJ, Pochi PE, Strauss JS. Isotretinoin treatment of acne and related disorders: an update. J Am Acad Dermatol 1983;9:629–638

    PubMed  CAS  Google Scholar 

  14. Leyden JJ. Oral isotretinoin. How can we treat difficult acne patients? Dermatology 1997; 195[Suppl 1]:29–33

    Article  PubMed  Google Scholar 

  15. Webster GF. Acne vulgaris. Br Med J 2002; 325:475–479

    Article  Google Scholar 

  16. Jansen T, Altmeyer P, Plewig G. Acne inversa (alias hidradenitis suppurativa). J Eur Acad Dermatol Venereol 2002; 15:532–540

    Article  Google Scholar 

  17. Jemec GBE. Medical treatment of hidradenitis suppurativa. Expert Opin Pharmacother 2004; 5:1767–1770

    Article  PubMed  CAS  Google Scholar 

  18. Jones H, Blanc D, Cunliffe WJ. 13-cis-retinoic acid and acne. Lancet 1983; ii:1048–1049

    Google Scholar 

  19. Plewig G, Nikolowsky J, Wolff HH. Action of isotretinoin in acne rosacea and gram-negative folliculitis. J Am Acad Dermatol 1982; 6:766–785

    PubMed  CAS  Google Scholar 

  20. Peck GL, Olsen TG, Butkus D, Pandya M, Arnaud-Battandier J. Isotretinoin versus placebo in the treatment of cystic acne. J Am Acad Dermatol 1982;6:735–745

    PubMed  CAS  Google Scholar 

  21. Harms M. Traitement de l’acné par l’isotretinoïne par voie buccale. Etude clinique sur 56 patients. Schweiz Med Wschr 1983; 42:1549–1554

    Google Scholar 

  22. Libow LF, Friar DA. Arthropathy associated with cystic acne, hidradenitis suppurativa, and perifolliculitis capitis abscedens et suffodiens: treatment with isotretinoin. Cutis 1999; 64:87–90

    PubMed  CAS  Google Scholar 

  23. Jemec GBE. Hidradenitis suppurativa. J Cutan Med Surg 2003; 7(1):47–56

    Article  PubMed  Google Scholar 

  24. Plewig G, Steger M. Acne inversa (alias acne triad, acne tetrad or hidradenitis suppurativa). In: Marks R, Plewig G, Eds. Acne and related disorders. Martin Dunitz, London, 1989; pp 345–538

    Google Scholar 

  25. Rödder-Wehrmann O, Küster W, Plewig G. Acne inversa. Diagnose und therapie. Hautarzt 1991; 42:5–8

    PubMed  Google Scholar 

  26. Hermann A, Preusser KP, Marsch WC. Die Acne inversa Hidradenitis suppurativa): Frühzeitig erken-nen und kurativ operieren. Chirurg 2000; 71:1395–1400

    Article  Google Scholar 

  27. Lentner A, Rübben A, Wienert V. Klinische Erscheinungsbild und Tharapie der Pyodermia fistulans significa. Symptomatology and therapy of hidradenitis suppurativa. Z Hautkr 1992; 67:988–992

    Google Scholar 

  28. Tsianos EV, Dalekos GN, Tzermias C, Merkouropoulos M, Hatzis J. Hidradenitis suppurativa in Crohn’s disease. J Clin Gastroenterol 1995; 20:151–153

    Article  PubMed  CAS  Google Scholar 

  29. Fearfield LA, Staughton RCD. Severe vulval apocrine acne successfully treated with prednisolone and isotretinoin. Clin Exp Dermatol 1998; 24:189–192

    Article  Google Scholar 

  30. Saurat JH. Side effects of systemic retinoids and their clinical management. J Am Acad Dermatol 1992; 27:S23–S28

    PubMed  CAS  Google Scholar 

  31. Barth JH, Macdonald-Hull SP, Mark J, Jones RG, Cunliffe WJ. Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol 1993; 129:704–707

    Article  PubMed  CAS  Google Scholar 

  32. Perlman SE, Leach EE, Dominguez L, Ruszkowski AM, Rudy SJ. Be smart, be safe, be sure. The revised pregnancy prevention program for woman on isotretinoin. J Reprod Med 2001; 46:179–185

    PubMed  CAS  Google Scholar 

  33. Pilkington T, Brogden RN. Acitretin. A review on its pharmacology and therapeutic use. Drugs 1992;43:597–627

    PubMed  CAS  Google Scholar 

  34. Stewart WD. Etretinate in other diseases of keratinization. In: The retinoids: a significant advance in dermatology. Medicines Publishing Foundation Symposium Series, Oxford, 1984; Series 14:51–55

    Google Scholar 

  35. Hogan DJ, Light MJ. Successful treatment of hidradenitis suppurativa with acitretin. J Am Acad Dermatol 1988; 19:355–356

    Article  PubMed  CAS  Google Scholar 

  36. Vahlquist A, Griffiths WAD. Retinoid therapy in hidradenitis suppurativa — report of a case. Retinoids Today Tom 1990; 18:28–30

    Google Scholar 

  37. Chow ETY, Mortimer PS. Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate. Br J Dermatol 1992; 126:415

    Article  PubMed  CAS  Google Scholar 

  38. Scheman AJ. Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report. Cutis 2002; 69:287–288

    PubMed  Google Scholar 

  39. Shalita AR, Fritsch PO. Retinoids: present and future. J Am Acad Dermatol 1992; 27:S1–S46

    Article  Google Scholar 

  40. Katz HI, Waalen J, Leach EE. Acitretin for psoriasis therapy. J Am Acad Dermatol 1998; 41:S7–S12

    Article  Google Scholar 

  41. Lowe NJ. Psoriasis: systemic retinoid treatment. In: Lowe N, Marks R, Eds. Retinoids. A clinician’s guide, 2nd edn. Martin Dunitz, London, 1998; pp 57–69

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Deventer Hospital, Postbox 5001, 7400 GC, Deventer, The Netherlands

    Jurr Boer

Authors
  1. Jurr Boer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Roskilde Hospital, Department of Dermatology, University of Copenhagen, Køgevej 7-13, 4000, Roskilde, Denmark

    Gregor B. E. Jemec MD, DMedSc

  2. Service Dermatologie, CHU Henri Mondor, Avenue Marechal de Lattre de Tassigny 51, 94010, Créteil, CX, France

    Jean Revuz MD, DMedSc

  3. Department of Dermatology, University Hospital of Pennsylvania, Spruce Street 3400, 19104, Philadelphia, USA

    James J. Leyden MD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Boer, J. (2006). Oral Retinoids for Hidradenitis Suppurativa. In: Jemec, G.B.E., Revuz, J., Leyden, J.J. (eds) Hidradenitis Suppurativa. Springer, Berlin, Heidelberg . https://doi.org/10.1007/978-3-540-33101-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33101-8_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-33100-1

  • Online ISBN: 978-3-540-33101-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation